PS
XENE icon

Principal Securities’s Xenon Pharmaceuticals XENE Stock Holding History

Principal Securities’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-68
Closed -$2.73K – 3522
2025
Q3 		$2.73K Hold
68
– – ﹤0.01% 3159
2025
Q2 		$2.13K Buy
68
+10
+17% +$326 ﹤0.01% 3129
2025
Q1 		$2.27K Hold
58
– – ﹤0.01% 3014
2024
Q4 		$2.27K Buy
58
+13
+29% +$537 ﹤0.01% 3008
2024
Q3 		$1.77K Buy
45
+24
+114% +$968 ﹤0.01% 2987
2024
Q2 		$819 Buy
21
+5
+31% +$200 ﹤0.01% 3107
2024
Q1 		$689 Hold
16
– – ﹤0.01% 3099
2023
Q4 		$737 Buy
+16
New +$565 ﹤0.01% 3015

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return